PRIMARY STUDY

Cannabis and Its Potential Protective Role Against Inflammatory Bowel Disease: A Scoping Review

Key Findings:  This retrospective study on the use of cannabis in inflammatory bowel disease (IBD) is found inconclusive evidence that cannabis is protective for IBD patients. It does appear to improve patient's perceptions of their well-being.

Type of Study:  Meta-analysis

Study Sample Size:  6

Study Result:  Inconclusive

Study Location(s):  United States

Year of Pub:  2022


Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabinoid (unspecified)

Phytocannabinoid Source:  Unspecified

Chemotype:  Chemotype I, Chemotype III

Route of Administration:  Inhalation, Oral (Ingestion)



Link to study